(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-20 View latest technical analysis
10 day averaged volume of Adaptimmune Therapeutics is 1086361
Date | Daily Closing Price | Open | High | Low | Volume |
20 Thu Mar 2025 | 0.28 | 0.43 | 0.43 | 0.26 | 12.93 times |
19 Wed Mar 2025 | 0.45 | 0.47 | 0.47 | 0.44 | 0.524 times |
18 Tue Mar 2025 | 0.46 | 0.46 | 0.47 | 0.45 | 0.463 times |
17 Mon Mar 2025 | 0.46 | 0.45 | 0.47 | 0.45 | 1.252 times |
14 Fri Mar 2025 | 0.45 | 0.45 | 0.47 | 0.44 | 0.722 times |
13 Thu Mar 2025 | 0.45 | 0.45 | 0.47 | 0.44 | 1.001 times |
12 Wed Mar 2025 | 0.46 | 0.45 | 0.48 | 0.44 | 0.75 times |
11 Tue Mar 2025 | 0.45 | 0.45 | 0.47 | 0.44 | 2.06 times |
10 Mon Mar 2025 | 0.45 | 0.48 | 0.49 | 0.45 | 2.132 times |
07 Fri Mar 2025 | 0.48 | 0.49 | 0.52 | 0.48 | 0.406 times |
Stock of Adaptimmune Therapeutics (ADAP) has showed a significant fall. This could be a good time to exit from this stock.
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 0.3, for a target of 0.4 or 0.49
Share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Target | 0.26 |
Upside Target | 0.44 |
Upside Target | 0.46 |
Upside Target | 0.47 |
Upside Target | 0.49 |
Upside Target | 0.51 |
Upside Target | 0.53 |
Upside Target | 0.61 |
Upside Target | 0.62 |
Upside Target | 0.67 |
Upside Target | 0.69 |
Upside Target | 0.86 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Intraday Target | 0.2 |
Downside Intraday Target | 0.13 |
Upside Intraday Target | 0.41 |
Upside Intraday Target | 0.55 |
Upside Intraday Target | 0.34 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Weekly Closing Price | Open | High | Low | Volume |
20 Thu Mar 2025 | 0.28 | 0.45 | 0.47 | 0.26 | 2.276 times |
14 Fri Mar 2025 | 0.45 | 0.48 | 0.49 | 0.44 | 1.263 times |
07 Fri Mar 2025 | 0.48 | 0.56 | 0.56 | 0.46 | 0.683 times |
28 Fri Feb 2025 | 0.54 | 0.56 | 0.62 | 0.51 | 2.865 times |
21 Fri Feb 2025 | 0.56 | 0.59 | 0.61 | 0.55 | 1.348 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Monthly Closing Price | Open | High | Low | Volume |
20 Thu Mar 2025 | 0.28 | 0.56 | 0.56 | 0.26 | 1.698 times |
28 Fri Feb 2025 | 0.54 | 0.57 | 0.62 | 0.51 | 0.66 times |
31 Fri Jan 2025 | 0.59 | 0.54 | 0.69 | 0.54 | 0.549 times |
31 Tue Dec 2024 | 0.54 | 0.65 | 0.67 | 0.53 | 1.108 times |
Scroll below to view daily charts
Price has moved down this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.35 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.35 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.